Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-05

ANNX vs OBX: stock comparison and AI forecast

Annexon, Inc. (ANNX) and Obsidian Therapeutics, Inc. (OBX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

ANNX Annexon, Inc.

Price
$4.33 -24.0% · 6M
Market Cap
$821M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

OBX Obsidian Therapeutics, Inc.

Market Cap
$679M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

ANNX · OBX

Key facts

  • ANNX is 1.2 times larger than OBX by market capitalization ($821M against $679M).
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricANNXOBX
Market Cap$821M$679M
P/B Ratio3.88x–
EPS$-1.28–
Book Value/Share$1.12–
FCF/Share$-1.02–

Profitability & Margins

MetricANNXOBX
ROE-91.4%–

Financial Health

MetricANNXOBX
Current Ratio5.53x2.30x
D/E Ratio0.31x–
Working Capital$174M$26M

Cash Flow

MetricANNXOBX
Operating Cash Flow-$193M–
Free Cash Flow-$193M–
Capital Spending-$180K–

Income Statement

MetricANNXOBX
Operating Income-$211M–
Net Income-$193M–
R&D Expense$175M–

Dividend & Shareholder Information

MetricANNXOBX
Shares Outstanding190M62M
FAQ

ANNX vs OBX: stock comparison and AI forecast

Which is bigger, ANNX or OBX?

ANNX is 1.2 times larger than OBX by market capitalization ($821M against $679M).

Which one does Intratio's AI model rank higher, ANNX or OBX?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.